| ARIPIPRAZOLE | None | ||
| 2MG, 5MG, 10MG, 15MG, 20MG, 30MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ABILIFY MYCITE, a drug-device combination product comprised of aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor intended to track drug ingestion, is indicated for the: • Treatment of adults with schizophrenia • Treatment of bipolar I disorder o Acute treatment of adults with manic and mixed episodes as monotherapy and as adjunct to lithium or valproate o Maintenance treatment of adults as monotherapy and as adjunct to lithium or valproate • Adjunctive treatment of adults with major depressive disorder (MDD) | |||
|
Yes
| |||
| ABILIFY MYCITE KIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 | Patent 24 | Patent 25 | Patent 26 | Patent 27 | Patent 28 | Patent 29 | Patent 30 | Patent 31 | Patent 32 | Patent 33 | Patent 34 | Patent 35 | Patent 36 | Patent 37 | Patent 38 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||||||||||||||||||||
| ************* ****** **** ******* ***** ****** | ****-********** ******** *** ****** | *****-**** ************* ********** ***** ******* *** *******, *** ******* ** ***** *** **** | ****** ******** ********** ***** ******* *** ******* *** ***** *** **** | *********** ****-**** ************** ****** | ******-*********** ****** | ****** ****** ********** ******** ****** ****** ********* | *********** *********** *** ********* ******** ********** *** ********* ** **** ********* | ******-*********** ****** | ********** ********** ********** ********** | **-**** ***** ****** ****** **** ******* **** ********* | **-**** ****** **** ******* ****** ****** ************* | *****-**** ************* ********** ***** ******* *** *******, *** ******* ** ***** *** **** | ******-*********** ****** | *********** *********** *** **** *********** *** ******** **** ********* | ****-********** ******** *** ****** | *****-**** ************* ********** ***** ******* *** *******, *** ******* ** ***** *** **** | *********, ******, *** ****** ** ********** ******** ***** *********** *** ********* ***** ** * ***** ****** *** * ************* ****** | *******, ******* *** ******* *** ********* *** ******** * ****** ** *** ******** ** ***** ***** ****** *** ******* | ****** ******** ********** ***** ******* *** ******* *** ***** *** **** | **-**** ****** **** ******* ****** ****** ************* | ****** ****** ********** ******** ****** ****** ********* | ****** *** ********* *** *** **** ******** *************** ****** ** * ********* *** ***** ******* ** ******* | *******, ******* *** ******* *** ********* *** ******** * ****** ** *** ******** ** ***** ***** ****** *** ******* | ****** *** ****** ***** ********** | *******, ******* *** ******* *** ********* *** ******** * ****** ** *** ******** ** ***** ***** ****** *** ******* | ********** ***** ****** ******* | ************* ****** **** ******** ******* ***** ****** *** ****** ** ************* **** | ************* ****** **** ******** ******* ***** ****** *** ****** ** ************* **** | **-**** ***** ****** ****** **** ******* **** ********* | ******-*********** ****** | *-**** ******** ******* ******* | ****** ** ******** ********* *********** *** ************** | *** *********** ************ **** ********* *** ********* *** *** *********** ******* | *** *********** ************ **** ********* *** ********* *** *** *********** ******* | *** *********** ************ **** ********* *** ********* *** *** *********** ******* | *********** *********** *** ********* ******** ********** *** ********* ** **** ********* | *** *********** ************ **** ********* *** ********* *** *** *********** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|